ALK and non-small cell lung carcinoma: According to the Vysis ALK Break Apart FISH evaluation guide for NSCLC tissue specimens and the summary of safety and effectiveness data provided by Abbott Molecular [8,9], the protocol is a two-step (50- to 100-cell) analysis approach (Figure 1), as follows: